N'dri Kadiane-Oussou to Humans
This is a "connection" page, showing publications N'dri Kadiane-Oussou has written about Humans.
Connection Strength
0.024
-
COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France). Microbes Infect. 2020 Nov - Dec; 22(10):622-625.
Score: 0.007
-
It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 02 11; 74(3):560-562.
Score: 0.002
-
Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials. Rev Med Virol. 2022 01; 32(1):e2239.
Score: 0.002
-
Comparison of COVID-19 and influenza in adult patients: Neurological symptoms input. J Med Virol. 2021 04; 93(4):1893-1895.
Score: 0.002
-
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients. Int J Infect Dis. 2020 Oct; 99:491-495.
Score: 0.002
-
New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France. Int J Infect Dis. 2020 Nov; 100:117-122.
Score: 0.002
-
Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes Infect. 2020 10; 22(9):481-488.
Score: 0.002
-
Coronavirus disease 2019: New things to know! J Med Virol. 2020 10; 92(10):1767-1768.
Score: 0.002
-
Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients. Infection. 2021 04; 49(2):361-365.
Score: 0.002
-
Diarrhea: An underestimated symptom in Coronavirus disease 2019. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):282-283.
Score: 0.002